EP1206190A1 - Vaccines for the treatment of autoimmune disease - Google Patents

Vaccines for the treatment of autoimmune disease

Info

Publication number
EP1206190A1
EP1206190A1 EP00957326A EP00957326A EP1206190A1 EP 1206190 A1 EP1206190 A1 EP 1206190A1 EP 00957326 A EP00957326 A EP 00957326A EP 00957326 A EP00957326 A EP 00957326A EP 1206190 A1 EP1206190 A1 EP 1206190A1
Authority
EP
European Patent Office
Prior art keywords
vac
mice
disease
ifa
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00957326A
Other languages
German (de)
English (en)
French (fr)
Inventor
Nanette Solvason
Simonetta Mocci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of EP1206190A1 publication Critical patent/EP1206190A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00957326A 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease Withdrawn EP1206190A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14762699P 1999-08-06 1999-08-06
US147626P 1999-08-06
PCT/US2000/021644 WO2001010221A1 (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
EP1206190A1 true EP1206190A1 (en) 2002-05-22

Family

ID=22522280

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00957326A Withdrawn EP1206190A1 (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Country Status (5)

Country Link
EP (1) EP1206190A1 (ja)
JP (1) JP2003510335A (ja)
AU (1) AU6896300A (ja)
CA (1) CA2378285A1 (ja)
WO (1) WO2001010221A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2305086T3 (es) * 2000-05-19 2008-11-01 Corixa Corporation Tratamiento profilactico y terapeutico de enfermedades alergicas, autoinmunes e infecciosas con compuestos con base de monosacaridos.
US20030139356A1 (en) 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030104012A1 (en) * 2001-05-11 2003-06-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
US11077179B2 (en) * 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
US5268170A (en) * 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0110221A1 *

Also Published As

Publication number Publication date
WO2001010221A1 (en) 2001-02-15
JP2003510335A (ja) 2003-03-18
CA2378285A1 (en) 2001-02-15
AU6896300A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
DE60132474T2 (de) Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung
US10286053B2 (en) Compositions and methods
EP2426141B1 (en) Method for preventing or treating M tuberculosis infection
JP7339942B2 (ja) サポニンを含むリポソーム製剤および使用方法
RU2732574C2 (ru) Синтетические глюкопиранозиллипидные адъюванты
KR20140053887A (ko) 면역 반응을 증진시키는 조성물 및 방법
HUE028452T2 (en) Mycobacterium antigenic preparations
JP7195148B2 (ja) Ｔｌｒアゴニストを含有する製剤及び使用方法
EA024826B1 (ru) Способ лечения латентного туберкулеза
JP2007508273A (ja) 免疫原性組成物
US8425913B2 (en) Immunogenic agents against Burkholderia pseudomallei and/or Burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from Burkholderia pseudomallei
WO2001010221A1 (en) Vaccines for the treatment of autoimmune disease
US8778356B2 (en) Vaccine
US20020044951A1 (en) Isolated and purified nonpeptide antigens from mycobacterium tuberculosis
US20030104012A1 (en) Vaccines for the treatment of autoimmune disease
EP1690549B1 (en) Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals
EP2341928B1 (en) Mycobacterium tuberculosis vaccine
WO2016160429A1 (en) Glycoconjugate vaccine for leishmaniasis
WO2002062319A2 (en) Microsphere delivery of mucin peptides
TW201718006A (zh) 水生物種中增強之免疫反應
WO2022236370A1 (en) Immunogenic composition
WO2001028581A1 (fr) Compositions medicinales pouvant inhiber gvhd
MX2007013240A (en) Novel method for preventing or treating m tuberculosis infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020306

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020306;LT PAYMENT 20020306;LV PAYMENT 20020306;MK PAYMENT 20020306;RO PAYMENT 20020306;SI PAYMENT 20020306

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050224